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Abstract
Background & Aims: Dietary saturated fatty acids contribute to the development of fatty liver and have pathogenic link to
systemic inflammation. We investigated the effects of dietary fat towards the pathogenesis of non-alcoholic fatty liver
disease by longitudinal in vivo magnetic resonance spectroscopy (MRS) and in vitro liquid chromatography coupled with
mass spectrometry (LC-MS).
Methods: All measurements were performed on rats fed with high fat diet (HFD) and chow diet for twenty four weeks.
Longitudinal MRS measurements were performed at the 12th, 18th and 24th weeks. Liver tissues were analyzed by LC-MS,
histology and gene transcription studies after terminal in vivo experiments.
Results: Liver fat content of HFD rats for all ages was significantly (P,0.05) higher compared to their respective chow diet
fed rats. Unsaturation indices estimated from MRS and LC-MS data of chow diet fed rats were significantly higher (P,0.05)
than HFD fed rats. The concentration of triglycerides 48:1, 48:2, 50:1, 50:2, 50:3, 52:1, 52:2, 52:3, 54:3 and 54:2 was
significantly higher (P,0.05) in HFD rats. The concentration for some polyunsaturated triglycerides 54:7, 56:8, 56:7, 58:11,
58:10, 58:9, 58:8 and 60:10 was significantly higher (P,0.05) in chow diet fed rats compared to HFD rats. Lysophospholipid
concentrations including LPC and LPE were higher in HFD rats at 24 weeks indicating the increased risk of diabetes. The
expression of CD36, PPARa, SCD1, SREBF1 and UCP2 were significantly upregulated in HFD rats.
Conclusions: We demonstrated the early changes in saturated and unsaturated lipid composition in fatty liver by in vivo
MRS and ex vivo LC-MS. The higher LPC concentration in HFD rats indicated a higher risk of developing diabetes. Early
metabolic perturbations causing changes in lipid composition can be evaluated by the unsaturation index and correlated to
the non alcoholic fatty liver disease.
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Introduction
Non alcoholic fatty liver disease (NAFLD) results from an
imbalance between lipid availability (from circulating lipid uptake
or de novo lipogenesis) and lipid disposal (via fatty acid oxidation
or triglyceride-rich lipoprotein secretion). The accumulated lipids
induce oxidative stress, resulting in production of cytokines and
reactive oxygen species which in turn activate apoptosis thereby
initiating a sequence of disease events from steatosis to nonalco-
holic steatohepatitis (NASH), which progress into fibrosis and
cirrhosis [1,2,3,4,5]. Hepatic steatosis causes insulin resistance
which may act as pathogenic link between obesity and its
metabolic complications [6,7]. Many patients suffering from
metabolic syndrome involving obesity, dyslipidemia, hypertension,
insulin-resistant type-2 diabetes mellitus and atherosclerotic
cardiovascular disease are associated with NAFLD [1,2,3,4,5].
The estimation of saturated and unsaturated lipids during the
transition of normal liver to NAFLD provides information on early
biochemical changes and may be utilized to evaluate response
during interventions including exercise and drugs. Indeed, the
composition of the fatty acids (FA, the building blocks for
triglyceride) in the triglycerides (TG) is suspected to contribute
to the pathogenesis of NAFLD. In particular, saturated fatty acids
play a prominent role in the progression of obesity and diabetes
[8,9,10,11]. Diets with high saturated fatty acids are associated
with insulin resistance and NAFLD [12]. Saturated fatty acids are
poorly oxidized compared to unsaturated fat and hence are more
likely to accumulate in insulin resistant tissues [13]. Saturated
PLOS ONE | www.plosone.org 1 March 2014 | Volume 9 | Issue 3 | e91436
lipids are also the most inhibitory lipids on insulin sensitivity
[14,15]. The degree of unsaturation of the FAs modulate the
metabolic signaling and energy metabolism [16]. As such, the
assessment of both the ratio of saturated and unsaturated fat in the
liver, as well as the quantity of fat in the liver represent an
important aspect in the pathogenesis of chronic liver disease and
metabolic disease.
Magnetic resonance spectroscopy (MRS) is a non-invasive
method for investigating metabolism allowing longitudinal studies
on humans and rodents. It estimates both the total fat content and
unsaturation index. However, its main limitation deals with the
impossibility of estimating the individual lipid composition. On
another hand, liquid chromatography with mass spectrometry
(LC-MS) permits analysis of individual saturated and unsaturated
lipids.
In this study, we used in vivo MRS to evaluate the longitudinal
changes in liver fat content and unsaturation, on rodents fed with a
high-fat diet (HFD). HFD is a significant source of fatty acids taken
up by the liver [17]. We identified the specific lipid species that are
altered in liver of HFD fed animals due to insulin resistance and
fatty liver conditions predisposed to diabetes.
Materials and Methods
Animals and Animal Diet
All animal experiments were approved by the institutional
animal care and use committee of the biological resource center,
A*STAR, Singapore. Male F344 rats (CLEA Japan, Inc. Tokyo,
Japan) were received at 4 weeks of age, placed in individual cages,
and randomly assigned to chow diet (n = 8) and HFD groups
(n = 8). The animals were fed with their respective diets from the
5th week until the completion of the study (24th week). The FA
composition of the HFD (Research Diets, New Brunswick, New
Jersey, USA) was 62.4% saturated fat, 30.7% monounsaturated
fat, 6.9% polyunsaturated fat.
Biochemical Measurements
We measured plasma triglyceride, glucose, cholesterol and
insulin levels at 12, 18 and 24 weeks of age. All the animals were
fasted for 13 hours before blood collection. Bleeding was
performed from the lateral tail vein using a rodent restrainer.
Plasma glucose, cholesterol and triglyceride were evaluated by
enzymatic colorimetric method using hexokinase, cholesterol
esterase, cholesterol oxidase and fossati steps respectively (Quest
Lab Pvt. Ltd Singapore). Plasma insulin was measured by using an
ultra-sensitive ELISA kit (Crystal Chem Inc., Illinois, USA). An
oral glucose tolerance test (OGTT) was performed at week 18 after
an overnight fasting. Glucose (2 g kg21) was administered to rats
by oral gavage injection and blood samples were collected from
the tail vein at 0, 10, 30, 60 and 120 min. The total area under the
glucose curve was determined from time 0 to 120 min (AUC 0–
120 min) after glucose administration as described in our earlier
work [18].
In vivo MR Imaging and Spectroscopy
All animals were subjected to magnetic resonance imaging
(MRI) and localized MRS. Prior to in vivo experiments, animals
were initially anesthetized with 3% isofluorane in a dedicated
chamber. During the course of MRS experiments, isofluorane
levels were reduced to 1.5–2.0% in combination with medical air
and medical oxygen. In vivo imaging and spectroscopy were
performed using a 7 T Bruker ClinScan (Siemens VB15) MRI/
MRS scanner equipped with a 72 mm volume resonator for RF
transmit and 20 mm receive only surface coil. Rats were
positioned prone on the surface coil with the liver on top of the
coil. The respiratory rate and body temperature were monitored
using physiological monitoring system (ML880 16/30 power lab
system, AD Instruments, Spechbach, Germany). The temperature
probe was placed in the rectum of the rat and body temperature
was maintained at 37uC by circulating hot water through a rat
cradle on which the animal was resting. In vivo measurements were
performed on animals in both the chow diet group and HFD
group at 12, 18 and 24 weeks of age. Volume localized point
resolved spectroscopy sequence (PRESS) with water suppression
experiments were performed on a 46464 mm3 voxel within the
liver using TR=4000 ms, TE= 13 ms, 128 averages, and 2048
complex points with a spectral width of 3500 Hz. A respiratory
triggered gating module was incorporated into the PRESS
sequence with a trigger delay of 20 ms and an animal breathing
stabilized at 60–65 cycles per minute. Water unsuppressed spectra
were acquired under identical conditions with similar parameters
but only 4 averages. Lipid estimates were corrected for T2
relaxation. Fat content was estimated by the ratio of n-methylene
signal (1.30 ppm) to the sum of n-methylene and water signals. An
unsaturation index was estimated using the ratio of olefinic signal
(5.30 ppm) to the sum of olefinic, methylenes (1.30 ppm and
2.06 ppm) and methyl signals (0.90 ppm) [19].
Liquid Chromatography Coupled with Mass
Spectrometry (LC-MS)
Animals were sacrificed at the 24th week just after the final in vivo
MR experiments. The liver tissues were snap frozen in liquid
nitrogen. Lipids were extracted and quantified using methodology
as described in our earlier work [20,21,22,23]. About 20–30 mg of
liver tissue was homogenized in 900 mL of chloroform/methanol,
1/2, v/v (Merck Pte. Ltd., Singapore) and incubated on a vacuum
chamber in a dark room for 1 h with agitation. After incubation,
0.3 mL of chloroform was added to the homogenate, followed by
0.4 mL of ice-cold water. The homogenate was then vortexed for
30 s followed by centrifugation for 2 min at 9000 rpm. The
bottom organic phase was carefully transferred to an empty tube
and 0.5 mL of ice-cold chloroform was added and re-extracted to
collect the residual lipids fractions. The two organic extracts were
then combined and dried under nitrogen. Individual classes of
polar lipids were separated using an Agilent 1200 HPLC system
before introduction into a 3200 Q-Trap mass spectrometer
(Applied Biosystems) with HPLC conditions: Luna 3-mm silica
column (i.d. 15062.0 mm), mobile phase A (chloroform:methano-
l:ammonium hydroxide, 89.5:10:0.5), mobile phase B (chloroform:-
methanol:ammonium hydroxide:water, 55:39:0.5:5.5); flow rate
300 mL min21; 5% B for 3 min, then linear increase of B up to 30%
in 24 min, follow by 5 min under these conditions, and then linear
change to 70% B in 5 min. Mass spectrometry was recorded under
both positive and negative electron-spray ionization (ESI) modes
depending on the fraction [21] (conditions: Turbo Spray source
voltage, 5000 and - 4500 V for positive and negative modes,
respectively) with EMS scan type (conditions: source temperature,
300uC; GS1: 40.00, GS2: 40.00, curtain gas: 25.). Various lipid
fractions including phosphatidylcholine (PC), sphingomyelin (SM),
ceramide (Cer) and Glucocyl-ceramide (GluCer) were acquired in
the positive ESI mode while phosphatidylethanolamine (PE),
phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylgly-
cerol (PG), phosphatidic acids (PA) and gangliosides mannoside 3
(GM3) were measured in the negative ESI mode [21]. Individual
lipid species were quantified by comparison with spiked internal
standards PC-14:0/14:0, PE-14:0-14:0, PS- 14:0/14:0, PA-17:0/
17:0, PG-14:0/14:0, d31-PI18:1/16:0, C17-LPC, C17-LPA, C17-
LPS, C17-Cer, C8-GluCer, C12-SM and C17-ganglioside GM3
Hepatic Lipid Composition by In Vivo MRS and LC-MS
PLOS ONE | www.plosone.org 2 March 2014 | Volume 9 | Issue 3 | e91436
obtained from Avanti polar lipids (Alabaster, AL, USA). The molar
fractions of individual lipid species and each lipid class were
normalized by summation of all polar lipid species. TGs were
separated from polar lipids on an Agilent Zorbax Eclipse XDB-C18
column (i.d. 15064.66 mm), with chloroform:methanol:0.1 M
ammonium acetate (100:100:4) as mobile phase at a flow rate of
0.25 mL min21. TGs were analyzed by using a modified version of
reversed phase HPLC/ESI/MS with d5-TG 48:0 (CDN isotopes)
as internal standard [22]. Cholesterol esters were analyzed with
corresponding d6-C18 cholesterol ester (CDN isotopes) as internal
standards [23]. The unsaturation index from the LC-MS data were
computed by the ratio of the absolute concentration of all
unsaturated lipids to the concentration of saturated lipids.
Triglycerides with no double bonds were defined as saturated, with
1 to 3 unsaturations as mono-unsaturated (considering up to one
double bond for each fatty acyl chain) and more than 3 double
bonds as poly-unsaturated. Two unsaturation indices were derived
considering either all unsaturated fatty acids (mono- and poly-
unsaturated, n$1) or only the poly-unsaturated ones (n.3).
mRNA Analysis
Total RNA was extracted from the liver samples using trizol
reagent (Invitrogen) and treated with DNase I prior to cDNA
conversion using the revertAid H minus first strand cDNA
synthesis kit (Fermentas, USA) with oligo d(T) 18 primer according
to manufacturer’s instructions. For real time qPCR, cDNA
samples were analyzed in triplicates using the SYBR Green
PCR Master Mix reagent kit (Applied Biosystems) on a
StepOnePlus Real-Time PCR System (Applied Biosystems).
Relative mRNA levels were calculated and normalized to
glyceraldehyde 3-phosphate dehydrogenase GAPDH (CAAGGT-
CATCCATGACAACTTTG) and (GGCCATCCACAGTCTT-
CTGA), used as an endogenous control gene. The primer
sequences used were as follows: peroxisome-proliferator-activated
receptor a; PPARa (TGTCATCACAGACACCCTCTCTC) and
(TCATCTGTACTGGTGGGGACA), sterol regulatory element
binding factor; SREBF1 (CTGCTTTGGAACCTCGTCCG) and
(GCCTCCTGTGTACTTGCCCAT), stearoyl-CoA desaturase
1; SCD1 (CCTACGACAAGAACATTCAATCTC) and (TT-
GATGTGCCAGCGGTACTCACTG). Fatty acid translocase;
CD36 (Rn02115479_g1), mitochondrial uncoupling protein 2;
UCP2 (Rn01754856_m1) (Taqmann, Life Technologies, CA,
USA).
Histology
Rat liver sections were stained for Oil Red O and hematoxylin
& eosin (H & E) to assess the fat accumulation and hepatocyte
inflammation, respectively. After the terminal study the livers were
excised and fixed in 10% formalin for 24 h and embedded in
paraffin wax after dehydration. Formalin fixed rat livers were
sectioned at 8 mm and slides were rinsed with PBS (pH 7.4). After
passing dry air, the slides were placed in 100% propylene glycol
for 2 min, and stained in 0.5% Oil Red O solution in propylene
glycol for 30 min. The slides were transferred to a 85% propylene
glycol solution for 1 min, rinsed in distilled water for 2 times and
processed for hematoxylin counter staining. The steatosis/
steatohepatitis was evaluated using a semi-quantitative scoring
system [24]. The scoring was based on a chow diet group of
animals for which if liver acini did not show lipid vacuoles, a score
of zero was given (baseline). Acini having lipid vacuoles up to 33%
(mainly macrovesicular type) were considered as score 1. Acini
with 34–66% of lipid vacuoles were scored 2 while acini having
over 66% of lipid vacuoles were ranked 3.
Data Analysis and Statistics
Spectroscopic data were processed and analyzed using the
LCmodel software [25]. Lipid concentrations for both chow diet
and HFD groups were estimated by fitting the resonances of
methyl, n-methylene, allylic methylene, and the unsuppressed
water signal. The results are expressed as the mean 6 s.e.m.
(standard error of the mean). Statistical analysis was performed by
MedCalc, with significant differences between means identified
using paired two-tailed t-test. Differences were considered
significant at P,0.05.
Unsupervised multivariate factor analysis was performed using
principal component analysis (PCA) (Unscrambler 10.2 software)
on all quantitative data measured through LC-MS techniques.
The PCA results are represented in terms of scores and correlation
loadings plots. These scores and correlation loading vectors
provide a concise and simplified description of the variance
hidden in the dataset [26,27]. In the current PCA model the term
‘explained validation variance’ (EVV), expressed in percentage, is
defined as the proportion of the variance in the data explained by
the model.
Results
Bodyweight and Biochemical Measurements
HFD fed animals gained significant body weight during the 9th
and 10th weeks. The average body weight of HFD group at the
12th, 18th and 24th week was significantly (P,0.001) higher than
chow diet group (Table 1). The relative increase in percentage
body weight of HFD rats at 12, 18 and 24 weeks were 20%, 35%
and 42% higher than the chow diet rats respectively. Blood plasma
glucose, insulin, total cholesterol and TG measured in HFD and
chow diet groups of rats are listed in Table 1. The total TGs
(P#0.002) and cholesterol content (P#0.001) of HFD animals
were significantly higher than the chow diet fed animals for all
measurements. The plasma glucose and insulin concentrations
after OGTT performed at 18 weeks are shown in Figure 1A and
B, respectively. Plasma glucose and insulin concentrations
calculated by the area under the curve from 0–120 mins were
significantly (P,0.001) higher in HFD fed rats compared to chow
diet fed rats. Plasma glucose and insulin concentration from 0–
120 mins for HFD rats was 29108 mg/dL and 876 mg/dL
compared to 22607 mg/dL and 296 mg/dL in chow diet fed rats
respectively. The plasma glucose and insulin concentrations of
HFD rats at the 12th, 18th and 24th weeks were significantly higher
(P,0.001) than chow diet fed rats (Table 1).
Magnetic Resonance Spectroscopy
The liver fat was measured longitudinally in chow diet and
HFD fed animals at the 12th, 18th and 24th weeks of age. Most of
the lipid resonances are well resolved at 7 T compared to lower
field magnets. The representative in vivo spectra obtained from
both HFD and chow diet fed rats are shown in Figure S1A and B.
The signals from methyl (0.9 ppm), n-methylene (1.30 ppm),
allylic methylene (2.06 ppm), a-methylene (2.20 ppm) and olefinic
(5.30 ppm) groups are assigned in the spectra. Figure 2A shows the
liver fat content of chow diet and HFD fed rats for different age
groups. Total liver fat contents of the HFD and chow diet fed
animals at 12 weeks were 15.1861.47% and 2.1160.12%,
respectively. At 18 weeks the fat content in HFD animals
increased to 18.1460.91% compared to the chow diet group
2.5560.23%. At 24 weeks the liver fat content increased to
20.9761.71% and 3.2960.13% for the HFD and chow diet
animals, respectively. The liver fat content was significantly
(P,0.001) higher in HFD animals compared to the chow diet
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group for all time points in the study. The liver fat of HFD fed
animals increased significantly with age from 12 to 18 to 24 weeks.
Figure 2B shows the unsaturation indices (UI) of chow diet and
HFD animals at different ages. The UI of chow diet fed animals
was always higher than the HFD fed group at all ages (P,0.005).
In vitro LC-MS Studies
The liver was harvested after the terminal in vivo study at 24
weeks and tissue samples were subjected to LC-MS analysis. The
mean TG content in HFD animals (Figure 3A) was
19836356 nmol/mL while it was significantly lower
(5116221 nmol/mL, P,0.001) for the chow diet group.
Figure 3B and C show the two unsaturation indices of HFD and
chow diet groups determined by considering as unsaturated FAs
either from n$1 or from n.3, respectively (both definitions given
in the materials and methods section). The unsaturation index for
the chow diet fed animals was significantly higher (P,0.002) when
considering the poly-unsaturated fatty acids for its calculation.
Figure 4 shows the saturated and unsaturated TGs in HFD and
chow diet groups. Individual concentrations are provided in Table
S1. The triglycerides 50:2, 50:1, 52:3, 52:2 and 52:1 were found to
be the most abundant (120.99 to 273.60 nmol/mL) and signifi-
cantly higher (P,0.05) in HFD rats than in the chow diet fed
group. Concentrations of the triglycerides 48:2, 48:1, 50:3, 54:2,
54:3 were in the range 56.73 to 85.44 nmol/mL in HFD rats. The
rest of the TG concentrations were in the lower range of 0.8 to
33.01 nmol/mL but were still higher in HFD rats compared to
chow diet fed rats (P,0.05). In chow diet group of animals the
concentrations of all the saturated TGs were in the lower range of
0.1 to ,50 nmol/ml. The unsaturated TGs including 50:4, 52:5,
52:4, 54:5, 54:4, and 57:4 with concentration in the range 5 to
102 nmol/ml in HFD rats were significantly (P,0.05) higher than
chow diet fed rats. However, the poly-unsaturated triglycerides
54:7, 56:8, 56:7, 58:11, 58:10, 58:9, 58:8 and 60:10 were
significantly higher (P,0.05) in chow diet fed rats than in HFD
rats.
In addition to the TGs, we also estimated the concentration of
phospholipids [PC, PE, PI, PG, PS, PA] and sphingolipids [SM,
Cer, GluCer, GM3]. Both chow diet and HFD fed groups exhibit
a similar concentration for each of the molecule studied (Figure
S2A and B), except for lysophospholipids (LPC and LPE, Table 2).
Total LPC levels, as well as the LPCs 18:1, 18:0 and 20:0 and
LPEs 16:0, 18:1 and 18:0 were significantly (P,0.05) higher in
HFD rats (Table 2). Cholesterol ester (CE) content evaluated using
LC-MS in HFD animals was higher 226650 nmol/mL than chow
diet group 1562 nmol/ml mL (P,0.001).
The PCA was performed on LC-MS data. The model optimally
fitted the data with 96% and 3% of the total variance explained on
PC1 and PC2, respectively. The PCA score plot (figure not shown)
of the quantitative LC-MS data showed well delineated clusters of
HFD and chow diet fed rats in the multidimensional space. The
Table 1. Biochemical and body weight measurements of chow diet and HFD fed rats.
Biochemical measurements Chow diet animals High fat diet animals*
12th week 18th week 24th week 12th week 18th week 24th week
Cholesterol (mg/dL) 46.24 49.06 53.64 119.50 133.37 151.63
Triglyceride (mg/dL) 78.54 82.65 85.97 401.74 423.61 469.94
Glucose (mg/dL) 102 115 122 136 148 164
Insulin (ng/mL) 1.14 1.31 1.40 4.26 4.71 5.21
Body weight (gm) 231 274 342 278 371 487
The blood plasma cholesterol, triglycerides, glucose, insulin and body weight were significantly (P,0.05).
* higher in HFD fed rats.
doi:10.1371/journal.pone.0091436.t001
Figure 1. OGTTmeasurements. Time course of oral glucose tolerance test measurements from (A) plasma glucose and (B) plasma insulin for chow
diet and HFD fed rats.
doi:10.1371/journal.pone.0091436.g001
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loading plot (Figure S3) highlighted those key metabolites which
were predominantly accounted for variability along PC1 and PC2
vectors. The PCA isolated the unsaturated TGs 52:2, 52:3, 52:1,
54:2, 50:2, 50:1, 48:2, 48:1, 50:3, 54:3 on PC1 axis and were
present in higher concentrations.
mRNA Analysis
The real-time PCR mRNA expression analysis of various genes
for both chow diet and HFD rats are shown in Figure 5. We found
an increased expression (P,0.05) of mRNA levels of fatty acid
translocase (CD36: 9 fold), peroxisome-proliferator-activated
receptor a (PPARa: 2.35 fold), sterol regulatory element binding
factor (SREBF1: 2.40 fold), stearoyl-CoA desaturase 1 (SCD1:
2.20 fold), mitochondrial uncoupling protein 2 (UCP2: 4.17 fold)
in the HFD animal livers.
Histopathologic Assessment of Hepatic Steatosis
Representative H & E and Oil Red O stained sections of 24
weeks old rat liver from HFD and chow diet animals are showed in
Figure 6A and B, respectively. The fat deposition (lipid droplets) in
stained sections of the HFD fed animals is of mixed type including
macrovesicular type where in either single large fat droplet
displacing the nucleus or the presence of smaller well-defined
intracytoplasmic droplets. Based on the scoring method [24], the
HFD fed animals showed histopatholgical features of hepatic
steatosis with a score of 3 indicating over 68% of acini were
occupied by lipid vacuoles compared to chow diet fed animals.
Accumulation of lipid vacuoles was of both macro- and micro-
vesicular patterns. There were clear, well delineated and the
cytoplasmic vacuoles in the hepatocytes were of variable sizes with
mainly midzonal and paracentral distributions. There were
6861.08% lipid vacuoles in the liver of HFD rats compared to
4.5961.54% only for the chow diet group. HFD animals displayed
histopatholgical features of hepatic steatosis.
Discussion
Dietary intake of high amounts of saturated FAs and low
amounts of polyunsaturated fatty acids can cause NAFLD [28]. In
this study, we investigated the longitudinal changes of lipid
composition in a high saturated fat diet fed rodent model using in
vivo MRS and LC-MS techniques.
Our HFD model showed significant weight gain starting at the
9th week. The blood plasma analysis of the HFD animals showed
hyperinsulinemia and hypertriglyceridemia confirming insulin-
Figure 3. Triglycerides and unsaturation indices estimated from LC-MS. Estimation of (A) total triglycerides (B) unsaturation indices (by
considering unsaturated FAs with n$1 and (C) unsaturation indices (by considering unsaturated FAs with n.3) at 24 weeks in high fat diet and chow
diet fed rats.
doi:10.1371/journal.pone.0091436.g003
Figure 2. Liver fat and unsaturation indices estimated by in vivo MRS. Estimation of (A) liver fat (%) and (B) unsaturation indices by in vivo
MRS from chow diet and high fat diet fed animals at the 12th, 18th and 24th weeks. Liver fat content was significantly (P,0.001) higher in HFD fed rats
and unsaturation indices were significantly (P,0.005) higher in chow diet fed rats for all age groups.
doi:10.1371/journal.pone.0091436.g002
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resistant conditions [29,30]. High saturated fat diet intervention
resulted in an increase of body weight, increase in triglycerides and
cholesterol which lead to the metabolic consequence of insulin
resistance from the 12th week. The liver fat of HFD groups as
assessed by MRS, was higher by 13–17% compared to the
respective chow diet groups. This was confirmed by measuring the
liver TG content by LC-MS and also on histology. Histology
results from HFD fed rats showed excessive accumulation of
triglycerides with 68% of lipid vacuoles occupying the hepatocytes
at 24 weeks. The 9-fold increase in CD36 mRNA expression in
HFD rat livers suggested enhanced fatty acid transport in the fatty
liver resulting in an increased demand for the oxidation of fatty
acids. Hepatic PPARa associated with the attenuation of insulin
signaling and hepatic steatosis was upregulated by 2.35 fold in
HFD rats. The SREBF1 was elevated 2.4 fold in HFD fed rats
implicating the cause of insulin resistance and hepatosteatosis as
confirmed by histology. Hepatic mitochondrial oxidant production
is one of the primary mechanisms that promotes oxidative stress
during NAFLD, NASH and type 2 diabetes conditions [31,32].
UCP2 is mitochondrial inner membrane protein present in variety
Figure 4. Saturated and unsaturated triglycerides by LC-MS. Concentrations of saturated and unsaturated TGs in HFD and chow diet fed rats
estimated by LC-MS at 24 weeks. Triglycerides C50:2, C50:1, C52:3, C52:2 and C52:1 were found to be most abundant (.100 nmol/ml) and
significantly higher in HFD fed rats compared to chow diet fed rats. Concentrations of other TGs were less than 100 nmol/ml but significantly higher
in HFD rats.
doi:10.1371/journal.pone.0091436.g004
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of tissues including liver (hepatocytes) and its main function
involves the control of mitochondria-derived oxidant production
[33,34,35]. Studies on different tissues of animal models confirmed
that the baseline expression of UCP2 gene in hepatocytes is
undetectable but it shows significant up-regulation in the liver
during pathologic conditions associated with steatosis [34]. The 4-
fold increased expression of UCP2 levels in HFD group supported
the involvement of UCP2 gene in the pathogenesis of NAFLD.
In addition, we showed that the FA composition of the liver is
altered by HFD feeding. The unsaturation indices as determined
by in vivo MRS at 12, 18 and 24 weeks and by LC-MS at 24 weeks
were significantly lower in HFD rats. The UIs estimated by MRS
using resonances of olefinic, methyl, methylene and allylic
methylene at 24 weeks showed a 2.6 fold increase in chow diet
fed rats. The UIs estimated by LC MS were 1.12 and 2.9 fold
higher in chow diet fed rats when considering both mono- and
poly-unsaturated FA and only polyunsaturated fatty acids,
respectively. This 2.9 fold higher UI obtained by calculating only
Table 2. Concentrations of LPCs and LPEs in liver tissues of
chow diet and HFD fed rats at 24 weeks.
LPC and LPE Chow diet (mmol/ml) HFD (mmol/ml) P value
LPC18:0 0.00636561024 0.0086661024 0.005
LPC18:1 0.00126661025 0.00236261024 ,0.005
LPC20:0 0.00276261024 0.0046561024 ,0.04
LPE16:0 0.01476161023 0.01846761024 ,0.005
LPE18:1 0.00236961025 0.00486561024 ,0.001
LPE18:0 0.0106661024 0.0176961024 0.001
Concentrations of lysophosphatidylcholines (LPC) and
lysophosphatidylethanolamines (LPE) were significantly higher in liver tissues of
HFD fed rats.
doi:10.1371/journal.pone.0091436.t002
Figure 5. mRNA expression analysis. mRNA expression of (A) CD36, (B) SREBF1, (C) PPARa, (D) SCD1, and (E) UCP2. The expression of all these
genes were significantly higher for HFD rats than for chow diet fed animals.
doi:10.1371/journal.pone.0091436.g005
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polyunsaturated fatty acids is comparable with the MRS result (2.6
fold). The in vivo MRS and in vitro LC-MS techniques provided
complimentary information and had a good agreement for the
estimation of unsaturation in chow diet and HFD fed groups. Both
methods demonstrated decreased unsaturation in HFD rats
compared to chow diet rats. The accuracy of estimating the
unsaturation by 1D MR methods can be improved by including
bi-allylic methylene (2.8 ppm) signal which is not well resolved.
Localized 2D L-COSY technique [36] provides improved spectral
resolution where J coupled multiplet resonances are dispersed over
two spectral dimensions. The L-COSY techniques has been
utilized to estimate unsaturation using the cross peaks generated
by the scalar couplings between olefinic and allylic, diallylic
methylene protons [37] in skeletal muscle. This technology can be
further developed for liver applications with appropriate motion
compensation and optimization of acquisition time within a
clinical setting.
The decrease in unsaturation in the HFD group might be due to
alteration in fatty acid composition because of changes in
desaturase expression or activities. Donelly et al. have shown that
dietary fatty acids contribute to the fatty acid pool in the liver [17].
As such, the high proportion of saturated fat and decreased
availability of polyunsaturated lipid components in the HFD
contributed to the low unsaturation index. Degree of unsaturation
can be influenced by the activity of desaturases. SCD1 catalyzes
the conversion of the saturated fatty acyl-CoAs, to their respective
monounsaturated fatty acyl CoAs. The SCD1 was up regulated in
the livers of HFD mice by 2.2 fold. SCD1 up regulation
contributed to increase in monounsaturated fatty acids (Table
S1). In spite of increased mono-unsaturation, the proportion of the
available saturated fatty acids was still abundant in the HFD group
resulting in lower unsaturation index. The upregulation of SCD1
in HFD rats confirmed its crucial role in the pathogenesis of diet-
induced hepatic insulin resistance [38]. It was established that rate-
limiting nature of desaturation enzymes contribute to the
development of the diabetic condition [39]. A reduced degree of
unsaturation was reported in the skeletal muscle of overweight and
obese subjects [40]. Earlier MRS studies showed the changes in
degree of unsaturation in skeletal muscle of normal, overweight
and obese human subjects [16] and bone marrow composition in
osteoporosis subjects [19]. Relatively high levels of saturated fatty
acids and low levels of polyunsaturated fatty acids are found in
individuals with insulin resistance and metabolic syndrome [41].
Our study suggested that the same phenomenon was observed in
the liver of rats fed with a HFD and may also be relevant to the
pathogenesis of NAFLD and insulin resistance associated with
high fat feeding.
We also noticed a decreasing trend of FA unsaturation in chow
diet fed rats over the age which might be due to the redistribution
of the fatty acid composition. It was shown that ageing can alter
liver mitochondrial membranes influencing the free radical
production and reduce unsaturation [42]. During ageing there is
a redistribution between types of unsaturated fatty acids resulting
in transition from highly unsaturated fatty acids to less unsaturated
fatty acids [43]. In addition, it was found that impairment in
activity of delta-6-desaturase (D6D) due to ageing process results in
decreased synthesis of n-6 and n-3 polyunsaturated fatty acids
which is also a contributing factor in reducing the unsaturation
index over time [44].
The multivariate analysis showed the triglycerides (52:2, 52:3,
52:1, 54:2, 50:2, 50:1, 48:2, 48:0, 48:1, 50:3, 54:3) accounted for
increased fat in the liver. Rhee et al. [45] showed that triglycerides
48:0, 48:1 and 52:1 in human plasma of diabetic individuals are
associated with increased risk of diabetes mellitus. Our current
results suggests that the accumulation of these fatty acids in liver
tissues of HFD fed rats may also be important in increasing the risk
of diabetes mellitus. Cholesterol ester hydrolase (CEH) plays a vital
role in hepatic cholesterol homeostasis and its activity is
proportional to production of cholesterol ester. Three fold higher
CEH activity was reported in patients with acute hepatitis
compared to normal livers [46,47]. In the present study the
excessive accumulation of cholesterol ester in HFD rats confirmed
the steatosis condition of the liver indicating the risk of hepatitis.
Increased incorporation of saturated fat and cholesterol into the
cell membranes increase the membrane rigidity thereby reducing
the number of insulin receptors and their affinity to insulin,
causing an insulin resistance in the local tissue. This increased
availability of hepatic saturated fatty acids in HFD fed animals
reduces hepatic fatty acid oxidation and triglyceride export. This
in turn would increase hepatic fatty acid and triglyceride synthesis
which would augment the triglyceride accumulation in the liver of
HFD fed animals. LPC is an important signaling molecule with
diverse biological functions and involved in regulating cellular
inflammation [48,49]. Plasma, liver and skeletal muscle LPC levels
are increased in the obese diabetic db/db mouse and these
findings support that LPC may be involved in mediating insulin
resistance in obesity [50]. Increased abundance of LPCs was
shown to induce hepatocellular death caused by mitochondrial
membrane depolarization [51,52].
The HFD fed rat livers showed increased concentration of
lysophospholipids (LPC and LPE). In particular, excessive
accumulation of LPC 18:1, 18:0, 20:0 and LPE 16:0, 18:0, 18:1
in HFD fed rats might be due to liver inflammation indicating the
increased risk of diabetes [53]. Production of these lysopho-
spholipids in vivo is usually mediated by the release and/or
activation of the enzyme phospholipase A2 (PLA2) under
inflammatory conditions. PLA2 is present in neutrophilic granu-
locytes and its activation under inflammatory condition is also
associated with generation of reactive oxygen species. In a recent
clinical study, the LPE and LPCs were significantly higher in
inflammatory livers compared to healthy liver as confirmed by 31P
MRS [54].
Figure 6. Liver histology. (A) Oil red O staining and (B) Hematoxylin-
eosin staining of HFD and chow diet fed rat liver tissues at 24 weeks.
The HFD fed rats showed histopathological features of hepatic steatosis
with a score of 3 indicating over 68% of acini occupied by lipid vacuoles
compared to chow diet fed rats.
doi:10.1371/journal.pone.0091436.g006
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In conclusion, HFD increased the total fat fraction, and altered
the fatty acid composition which might be due to the composition
of the diet, or alterations in desaturase enzymes. The change in
unsaturation is relevant to the pathogenesis of NAFLD and insulin
resistance. Perturbations in lysophospholipids (LPC and LPE)
might provide early information on oxidative stress/inflammation
in NAFLD before the incidence of diabetes. These markers may
be useful to study the link between a HFD and medical conditions
in humans. Further studies are required to explore the possibilities
of using unsaturation index in scaling the severity of the NAFLD
in clinical practice. These studies could be extrapolated to evaluate
the metabolic response during interventions including exercise and
drugs.
Supporting Information
Figure S1 In vivo liver spectra from HFD and chow diet
fed rats. Representative in-vivo liver spectra from (A) HFD and
(B) chow diet fed rats. The signals from methyl (0.9 ppm), n-
methylene (1.30 ppm), allylic methylene (2.06 ppm), a-methylene
(2.20 ppm) and olefinic (5.3 ppm) groups are assigned in the
spectra.
(TIF)
Figure S2 Concentration of phospholipids and sphin-
gholipids from HFD and chow diet fed rats. A. Concen-
trations of sphingomyelin (SM), ceramide (Cer), phosphatidylcho-
line (PC), phosphatidylethanolamine (PE), phosphatidylinositol
(PI), phosphatidylserine (PS). B. Glucocyl-ceramide (GluCer),
phosphatidic acids (PA), phosphatidylglycerol (PG), gangliosides
mannoside 3(GM3) in HFD and chow diet fed rats.
(TIF)
Figure S3 Multivariate analysis of lipid components.
Multivariate analysis of lipid components in HFD and chow diet
fed rats. Loading plot highlighted the key TGs contributing to the
maximum variance between the two groups.
(TIF)
Table S1 Concentrations of saturated and unsaturated
triglycerides. Concentrations of saturated and unsaturated
triglycerides in liver of chow diet and HFD fed rats at 24 weeks
(DOCX)
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